Hamilton Thomas Edward

SEC source: 0001193125-26-298523 · ownership.xml · nonDerivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 714,798

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

SEC source: 0001769848-26-000002 · wk-form4_1781294647.xml · derivative · entry 3

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,884

Underlying: Common Stock · 8,641 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2020 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.exercise_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2020 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.expiration_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2020 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above.

F2 · balance_after: Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions.

SEC source: 0001193125-26-232644 · ownership.xml · derivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,150

Underlying: Common Stock · 55,150 shares

Expires 2036-05-19

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 19, 2027 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

SEC source: 0001193125-26-085515 · ownership.xml · nonDerivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 664,798

F1 · shares: Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026.

SEC source: 0001628280-25-025929 · wk-form4_1747340192.xml · derivative · entry 3

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,243

Underlying: Common Stock · 8,961 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.exercise_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.expiration_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F2 · balance_after: Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions.

SEC source: 0001062993-25-009378 · form4.xml · derivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2035-05-13

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 13, 2026 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

SEC source: 0001062993-24-011568 · form4.xml · derivative · entry 3

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2034-05-29

F2 · derivative.exercise_date: The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

SEC source: 0001628280-24-024178 · wk-form4_1715982252.xml · derivative · entry 3

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,282

Underlying: Common Stock · 8,583 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.exercise_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.expiration_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan, as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F2 · balance_after: Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions.

SEC source: 0001062993-24-011568 · form4.xml · nonDerivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 564,798

F1 · shares: Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. (the "Company") at the offering price, which closed on February 16, 2024.

SEC source: 0001628280-23-019100 · wf-form4_168452956622468.xml · derivative · entry 3

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,698

Underlying: Common Stock · 8,167 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.exercise_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.expiration_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F2 · balance_after: Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions.

SEC source: 0001062993-23-010807 · form4.xml · derivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,300

Underlying: Common Stock · 8,300 shares

Expires 2033-05-09

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 9, 2024 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

SEC source: 0001062993-22-019753 · form4.xml · nonDerivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 507,590

F1 · shares: Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022.

SEC source: 0001628280-22-015065 · wf-form4_165308061680864.xml · derivative · entry 3

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,124

Underlying: Common Stock · 24,372 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.exercise_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.expiration_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F2 · balance_after: Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions.

SEC source: 0001062993-22-012305 · form4.xml · derivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,300

Underlying: Common Stock · 8,300 shares

Expires 2032-05-10

F1 · derivative.exercise_date: The options vest on the earlier of (a) May 10, 2023 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

SEC source: 0001192482-21-000601 · edgar.xml · nonDerivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,130

SEC source: 0001628280-21-010935 · wf-form4_162163589491694.xml · derivative · entry 3

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,752

Underlying: Common Stock · 15,609 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.exercise_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.expiration_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan or the Annaly Capital Management, Inc. 2020 Equity Incentive Plan as applicable. The reporting person has elected such deferred settlement for all DSUs reported above.

F2 · balance_after: Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions.

SEC source: 0001192482-21-000438 · edgar.xml · derivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,300

Underlying: Common Stock · 8,300 shares

Expires 2031-05-12

F1 · derivative.exercise_date: The Option vests on the earlier of (a) May 12, 2022 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

SEC source: 0001628280-21-008886 · wf-form4_162016025387022.xml · nonDerivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · 2012 Hamilton Family Trust

Disclosed balance after: 0

F1 · kind: The sale was made in connection with the reporting person's estate planning

F2 · price: This transaction was executed in multiple trades at prices ranging from $9.18 to $9.185. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected

SEC source: 0001192482-20-000751 · edgar.xml · derivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,600

Underlying: Common Stock · 16,600 shares

Expires 2030-07-16

F1 · derivative.exercise_date: The Option was granted on July 16, 2020 subject to stockholder approval, which was obtained at the Company's special meeting of stockholders on September 29, 2020. The vesting commencement date for the option is July 16, 2020, and the option vests in equal monthly installments over 36 months, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date.

SEC source: 0001192482-20-000588 · edgar.xml · nonDerivative · entry 2

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · FA Life Sciences, Inc.

Disclosed balance after: 292,853

F2 · kind: Pro rata distribution from Holdings to its members, for no consideration.

SEC source: 0001192482-20-000588 · edgar.xml · nonDerivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,420

F1 · kind: Pro rata distribution from Chondrial Therapeutics Holdings, LLC ("Holdings") to its members, for no consideration. The reporting person is a member of the board of managers of Holdings.

SEC source: 0001628280-20-008269 · wf-form4_159017007389681.xml · derivative · entry 4

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,143

Underlying: Common Stock · 22,551 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.exercise_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.expiration_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above.

F2 · balance_after: Reflects the aggregate amount of DSUs granted during the tenure of the respective director net of any conversions.

SEC source: 0001628280-20-007917 · wf-form4_158957628368975.xml · nonDerivative · entry 2

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Cure FA Foundation, Inc.

Disclosed balance after: 330,000

F1 · price: The price reported above reflects the weighted average purchase price. The highest price at which the shares were purchased was $5.97 and the lowest price at which the shares were purchased was $5.945. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote in this Form 4.

SEC source: 0001628280-19-007193 · wf-form4_155872151122430.xml · derivative · entry 4

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,592

Underlying: Common Stock · 15,592 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.exercise_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above.

F1 · derivative.expiration_date: The Deferred Stock Units ("DSUs") convert to shares of Common Stock on a one-for-one basis one year after the date of grant unless the director elects to defer the settlement of the DSUs until after a termination of service pursuant to the Annaly Capital Management, Inc. 2010 Equity Incentive Plan. The reporting person has elected such deferred settlement for all DSUs reported above.

SEC source: 0001628280-19-007010 · wf-form4_155835047039247.xml · nonDerivative · entry 3

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · 2012 Hamilton Family Trust

Disclosed balance after: 80,000

SEC source: 0001628280-19-007010 · wf-form4_155835047039247.xml · nonDerivative · entry 2

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Cure FA Foundation, Inc.

Disclosed balance after: 130,000

SEC source: 0001628280-19-007010 · wf-form4_155835047039247.xml · nonDerivative · entry 1

Hamilton Thomas Edward · CIK 0001769848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,000

F1 · price: The price reported above reflects the weighted average purchase price. The highest price at which the shares were purchased was $9.470 and the lowest price at which the shares were purchased was $9.465. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote in this Form 4.